Taysha Gene Therapies, Inc. company logo
Taysha Gene Therapies, Inc. logo

Taysha Gene Therapies, Inc. (TSHA) Cash From Financing

Annual CFF

$76.68M$59.71M-43.78%

Summary

Current Value
As of today, TSHA annual cash from financing is $76.68M, down -43.78% on
Historical Performance
TSHA annual cash from financing is up +96.21% over the past 3 years, and up +100.00% over the past 5 years
All-Time High Comparison
TSHA annual cash from financing is currently -73.65% below its historical high of $291.06M set on
3-Year Low Comparison
TSHA annual cash from financing is +47.19% above its 3-year low of $52.10M reached on an earlier date
Sector Comparison
TSHA annual cash from financing is higher than 79.05% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TSHA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$76.68M-43.8%+96.2%+100.0%+100.0%
Quarterly Cash From Financing$8.80M+33.4%+8640.8%-96.8%
TTM Cash From Financing$224.66M+208.6%+1025.0%-23.2%
Price$5.14+166.3%+155.7%-81.1%
Annual Cash From Operations-$81.23M-11.2%+30.6%-100.0%-100.0%
Annual Cash From Investing-$363.00K+95.1%+98.3%-100.0%-100.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$63.95M+4.7%+1.4%+100.0%+100.0%
Shares Outstanding273.92M+33.7%+333.4%+625.4%

Cash From Financing Highs

TSHA Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$136.39M-43.8%
5Y$291.06MN/A-73.7%
All$291.06M-73.7%

Cash From Financing Lows

TSHA Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$52.10MN/A+47.2%
5Y$39.08M+96.2%
All$0.00N/A

Cash From Financing History

YearValueChange
$76.68M-43.8%
$136.39M+161.8%
$52.10M+33.3%
YearValueChange
$39.08M-86.6%
$291.06M>+9,900.0%
$0.00-

FAQ

  • What is the current annual cash from financing of TSHA?

    As of today, TSHA annual cash from financing is $76.68M

  • What is 1-year change in TSHA annual cash from financing?

    TSHA annual cash from financing is down -43.78% year-over-year

  • What is 3-year change in TSHA annual cash from financing?

    TSHA annual cash from financing is up +96.21% over the past 3 years

  • How far is TSHA annual cash from financing from its all-time high?

    TSHA annual cash from financing is currently -73.65% below its historical high of $291.06M set on December 31, 2020

  • How does TSHA annual cash from financing rank versus sector peers?

    TSHA annual cash from financing is higher than 79.05% of companies in Healthcare sector

  • When is TSHA next annual earnings release?

    The next annual earnings release for TSHA is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. TSHA Official Website www.tayshagtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1806310/000119312525263506/0001193125-25-263506-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1806310/000095017025027348/0000950170-25-027348-index.htm
  4. TSHA Profile on Yahoo Finance finance.yahoo.com/quote/TSHA
  5. TSHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tsha